NCT04644575: Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A
- State
- Under way
- Phase
- Phase 3
- People
- 261 taking part
- Started
- 23 Feb 2021
- Primary completion
- 15 Jan 2027
- Arms
- Arm A: Previously treated in BIVV001 study, Arm B: Newly initiated (China Only) in BIVV001, Arm C: Newly initiated in BIVV001 with planned major surgery
- Results
- None posted
- 25 Nov 2020: Trial registered
- 23 Feb 2021: Trial started